SOX2 peptide

Description

Antigenic peptide from the master transcriptional regulator SOX2 which plays an essential role during mammalian embryogenesis

See full description

Catalogue number crb1200402
Antibody Anti-SOX2 antibody
Antigen Peptide SOX2 peptide
Protein ID UniProtKB - P48431
Aliases Transcription Factor SOX-2, Sex Determining Region Y-Box, SRY-Box
Cross-Reactivity Human
Storage -20°C
References

Rothenberg, S., Concannon, K., Cullen, S., Boulay, G., Turke, A., Faber, A., Lockerman, E., Rivera, M., Engelman, J., Maheswaran, S. and Haber, D. (2015). Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways. eLife, 4. PMID: 25686219

 

Wuebben, E. and Rizzino, A. (2017). The dark side of SOX2: cancer - a comprehensive overview. Oncotarget, 8(27). PMID: 28388544

Specificity Protein
The pluripotency-associated master transcriptional regulator SOX2 is essential during mammalian embryogenesis, embryonic stem cell maintenance and later in life, however SOX2 expression can also be highly detrimental. SOX2 has been shown to be expressed in at least 25 different cancers, consequently, too little or too much SOX2 can dramatically alter tumour growth. SOX2 is therefore tightly regulated at the transcriptional level, by microRNAs, long non-coding RNAs, and post-translational modifications.

SOX2 represses the expression of pro-apoptotic molecules that mediate cell death following oncogene withdrawal in these cells. The induction of SOX2 results from the activation of FOXO6, a forkhead family transcription factor following EGFR inhibition. SOX2 may therefore be a valuable target for cancer therapy.

SOX2 peptide

Cat No. Pack Size Price Qty

crb1200402e

50ug

$112.50